Medicus PharmaMDCX

13F holders, Q3 2025 (September 30)
20holders −1
7new positions
8sold out
$2.31avg. 13F price*

At the end of Q3 2025, 20 institutions reported holding Medicus Pharma Ltd. (MDCX) in their 13F filings, down 1 from Q2 2025. 7 opened new positions and 8 sold out. The largest holders were Interchange Capital Partners, LLC ($3.7M), Yorkville Advisors Global, LP ($532K) and Private Advisor Group, LLC ($351K).

Company
Medicus Pharma Ltd.
CUSIP
58471K202
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q4 2024: 3Q4 2024Q1 2025: 7Q1 2025Q2 2025: 21Q2 2025Q3 2025: 20Q3 2025Q4 2025: 21Q4 2025Q1 2026: 21Q1 2026Q2 2026: 23Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions7$177K
Exits8$729K

All 13F filers, Q2 2025 → Q3 2025: 206,889 shares bought and 293,474 shares sold, net −86,585 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

Interchange Capital Partners, LLC 0.72% No change 1,586,871 $3.7M
Yorkville Advisors Global, LP 0.21% Add +117.3% 230,000 $532K
Private Advisor Group, LLC 0.00% Add +3.8% 151,500 $351K
Wilmington Savings Fund Society, FSB 0.00% New 25,622 $59K
Brave Asset Management Inc. 0.01% New 20,000 $46K
LPL Financial LLC 0.00% New 18,751 $43K
May Hill Capital, LLC 0.01% Reduce -50.0% 17,811 $41K
BlackRock, Inc. 0.00% Add +2.9% 16,216 $38K
Osaic Holdings, Inc. 0.00% No change 14,000 $31K
Base Wealth Management LLC 0.02% No change 11,543 $27K
Commonwealth Equity Services, LLC 0.00% New 10,882 $25K
UBS Group AG 0.00% Reduce -77.5% 6,957 $16K
Morgan Stanley 0.00% Reduce -49.1% 5,968 $14K
Larson Financial Group LLC 0.00% Reduce -68.0% 1,000 $2K
FNY Investment Advisers, LLC 0.00% New 1,000 $2K
Jones Financial Companies LLLP 0.00% No change 400 $1K
Dagco, Inc. 0.00% Reduce -0.3% 349 $808
EverSource Wealth Advisors, LLC 0.00% New 300 $695
Citigroup Inc. 0.00% New 222 $514
Wells Fargo & Company 0.00% No change 75 $174

"% of holder's portfolio" is MDCX's weight in each manager's 13F, not the share of Medicus Pharma Ltd. the manager owns.